Allergan Inc., known for Botox but also a maker of eye care products, and eye care company Alcon Inc. said Thursday that they agreed to settle two lawsuits over patent infringement charges. Both lawsuits were filed by Allergan. The first, filed in Delaware, involved patents covering Allergan's Alphagan glaucoma treatment. Allergan charged that Alcon violated patents by pursuing products that contained brimonidine, the active ingredient in Alphagan.

Posted by GEN-ERIC at 02:51:54 am into the following categories: In The News

---

http://gen-eric.com/patents/htsrv/trackback.php/606

Name:

Email: (not displayed on this site)

Site/Url:

Comment text:

Allowed XHTML tags: <p, ul, ol, li, dl, dt, dd, address, blockquote, ins, del, a, span, bdo, br, em, strong, dfn, code, samp, kdb, var, cite, abbr, acronym, q, sub, sup, tt, i, b, big, small>

URLs, email, AIM and ICQs will be converted automatically.

Options:
Auto-BR (Line breaks become <br />)
Remember me (Set cookies for name, email & url)